Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524669 | NSE Symbol : HESTERBIO | ISIN : INE782E01017 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
22-Jan-2025	30-Jan-2025	Quarterly Results	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months period ended 31 December 2024 Outcome of Board Meeting held on 30 January 2025 (As Per BSE Announcement dated on 30.01.2025)
21-Oct-2024	28-Oct-2024	Quarterly Results	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2024. Outcome of Board Meeting (As Per BSE Announcement Dated on 28.10.2024)
25-Jul-2024	02-Aug-2024	Quarterly Results	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended 30 June 2024. Outcome of Board Meeting Financial Results Q1 FY25 (As Per BSE Announcement Dated on 02.08.2024)
02-May-2024	10-May-2024	Dividend	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended 31 March 2024 and to consider the declaration of dividend if any on the equity shares of the Company for the financial year 2023-24. Outcome of Board Meeting (As Per BSE Announcement Dated on 10.05.2024)
24-Jan-2024	02-Feb-2024	Quarterly Results	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve standalone and consolidated unaudited financial results for the quarter and nine months period ended 31 December 2023 Outcome of Board meeting held today Financial Results for the period ended 31 December 2023 (As Per BSE Announcement Dated on 02/02/2024)
27-Oct-2023	07-Nov-2023	Quarterly Results	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended 30 September 2023. Unaudited Financial Results for the quarter and half year ended 30 September 2023. Outcome of Board Meeting held on 7 November 2023 (As Per BSE Announcement Dated on 07.11.2023)
31-Jul-2023	08-Aug-2023	Quarterly Results	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter ended 30 June 2023. Outcome of Board Meeting held in 8 August 2023 Unaudited standalone and consolidated financial results for the quarter ended 30 June 2023 (As Per BSE Announcement dated on 08.08.2023)
26-Jun-2023	26-Jun-2023	Change in Directors	Outcome of Board Meeting- Appointment of Independent Directors Appointment of Independent Directors
09-May-2023	17-May-2023	Accounts	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2023 inter alia to consider and approve the standalone and consolidated audited financial results of the Company for the quarter and year ended 31 March 2023 and to consider the declaration of dividend if any on the equity shares of the Company for the financial year 2022-23. Board approved:- 1. Recommended dividend of INR 8 (eight) per equity share of INR 10 each (80%) for the financial year 2022-23, subject to approval of members at the ensuing Annual General Meeting. 2. Re-appointment of Chandulal M. Shah & Co., Chartered Accountants (FRN: 101698W), Ahmedabad, as a Statutory Auditor of the Company for second term of 5 (five) consecutive years to hold office from the conclusion of the 36th Annual General Meeting till the conclusion of 41st Annual General Meeting of the Company, as recommended by Audit Committee, subject to approval of members at the ensuing annual general meeting. (As Per BSE Bulletin Dated on 17.05.2023) Outcome of Board Meeting held on 17 May 2023 Outcome of Board Meeting (As Per BSE Announcement Dated on 17.05.2023)
24-Jan-2023	31-Jan-2023	Quarterly Results	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and nine months ended 31 December 2022. Outcome of the Board Meeting held on 31 January 2023 Financial Results for Q3 & 9M FY23 (As Per BSE Announcement Dated on 31.01.2023)
22-Oct-2022	04-Nov-2022	Quarterly Results	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2022 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended 30 September 2022. Outcome of Board Meeting held on 4 November 2022 Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended30 September 2022 (As Per BSE Announcement dated on 04.11.2022)
02-Aug-2022	10-Aug-2022	Quarterly Results	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter ended 30 June 2022. Outcome of Board Meeting held on Wednesday, 10 August 2022 an Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2022 Financial Results for the quarter ended 30 June 2022 (As Per BSE Announcement dated on 10.08.2022)
12-May-2022	20-May-2022	Dividend	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2022 inter alia to consider and approve the standalone and consolidated audited financial results of the Company for the quarter and year ended 31 March 2022 and to consider declaration of dividend if any on the equity shares of the Company for the financial year 2021-22. The Board has recommended dividend of 100% that is INR 10 per equity share of INR 10 each for the financial year 2021-22, subject to approval of members in the ensuing Annual General Meeting. Outcome of Board Meeting (As Per BSE Announcement Dated on 20.05.2022)
07-Apr-2022	07-Apr-2022	Others	Outcome of Board Meeting held on Thursday, 7 April 2022.
20-Jan-2022	31-Jan-2022	Quarterly Results	HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2022 inter alia to consider and approve the standalone and consolidated unaudited financial results of the company for the Quarter and Nine Months ended 31 December 2021 Outcome of Board of Directors Meeting held on 31 January 2022 (As Per BSE Announcement Dated on 31.01.2022)

1 2

LOGIN HERE

Hester Biosciences Ltd

Board Meeting